Skip to main content
Clinical Trials/CTRI/2017/03/008177
CTRI/2017/03/008177RecruitingPhase 1

A clinical evaluation of Pippalyadi nasal spray for its Nasanahapratishedha activity in Nasanaha with special reference to Nasal blockage

Government Akhandanand Ayurved Mahavidhyalay0 sites30 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patient having pratishyÄ?ya with the symptom of NÄ?sÄ?nÄ?ha (nasal blockage) and without fever.
  • Chronic simple rhinitis with the symptom of NÄ?sÄ?nÄ?ha (nasal blockage) less than 6 month.
  • Hypertrophic rhinitis with the symptom of NÄ?sÄ?nÄ?ha (nasal blockage) less than 6 month.
  • NÄ?shÄ?rsha (1st degree nasal polyp)

Exclusion Criteria

  • Congenital anomalies of nose
  • rhinitis with fever
  • Atrophic rhinitis
  • Rhinitis sicca
  • 2nd and 3rd degree nasal polyp
  • Deviated nasal septum require surgical correction
  • Perforation of nasal septum
  • Septal haematoma
  • Septal abscess
  • bronchial asathama
  • Perennial rhinitis

Investigators

Sponsor
Government Akhandanand Ayurved Mahavidhyalay

Similar Trials